The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Study of the expression of integrin pathway's proteins as predictive markers of response to neoadjuvant chemotherapy in pretreatment biopsies of patients with high-grade osteosarcoma.
Elizabeth Laurence Cohen-Jonathan Moyal
No relevant relationships to disclose
Sophie Le Guellec
No relevant relationships to disclose
Thomas Filleron
No relevant relationships to disclose
Marie-Bernadette Delisle
No relevant relationships to disclose
Christine Chevreau
No relevant relationships to disclose
Herve Rubie
No relevant relationships to disclose
Marie Pierre Castex
No relevant relationships to disclose
Henri Hubert Roche
No relevant relationships to disclose
Jerome Sales De Gauzy
No relevant relationships to disclose
Paul Bonneviale
No relevant relationships to disclose
Anne Brouchet
No relevant relationships to disclose